Loading…
Reported covered position: 2006-07: Counselor to The Honorable Michael O. Leavitt
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ROCHE DIAGNOSTICS CORPORATION, INC. via MCDERMOTT WILL & SCHULTE LLP
2010 · fourth_quarter · Q4
Issues affecting FDA regulation of medical devices.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2010 · fourth_quarter · Q4
Source: Senate LDA
| HOSPITAL GEOGRAPHIC FAIRNESS COALITION |
| 2 |
| 2008–2009 |
| ROCHE DIAGNOSTICS CORPORATION, INC. | 2 | 2010 |
| SANOFI-AVENTIS U.S. INC. | 2 | 2009 |
| ALLERGAN, INC. | 1 | 2009 |
| CYTOMEDIX, INC. | 1 | 2008 |
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SPECIALTY HEALTH, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
American Middle Class Tax (AMT) Relief Act of 2007
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SPECIALTY HEALTH, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
American Middle Class Tax (AMT) Relief Act of 2007
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Superfund Polluter Pays Act
Client: AMERICAN SPECIALTY HEALTH, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
Superfund Polluter Pays Act
Client: AMERICAN SPECIALTY HEALTH, INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220..
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220..
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
Affordable Health Choices Act
Client: SANOFI-AVENTIS U.S. INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA approval of follow on biologics, including S. 1679
Affordable Health Choices Act
Client: SANOFI-AVENTIS U.S. INC. · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA approval of follow on biologics, including S. 1679
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests. Seeking TRICARE coverage for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ISIS PHARMACEUTICALS via MCDERMOTT WILL & SCHULTE LLP
2010 · fourth_quarter · Q4
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ISIS PHARMACEUTICALS via MCDERMOTT WILL & SCHULTE LLP
2010 · third_quarter · Q3
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ROCHE DIAGNOSTICS CORPORATION, INC. via MCDERMOTT WILL & SCHULTE LLP
2010 · third_quarter · Q3
Issues affecting FDA regulation of medical devices.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2010 · third_quarter · Q3
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests. Seeking TRICARE coverage for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2010 · second_quarter · Q2
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests. Seeking TRICARE coverage for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2010 · second_quarter · Q2
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ISIS PHARMACEUTICALS via MCDERMOTT WILL & SCHULTE LLP
2010 · second_quarter · Q2
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.
Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.
AMERICAN SPECIALTY HEALTH, INC. via MCDERMOTT WILL & SCHULTE LLP
2010 · second_quarter · 2T
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
ISIS PHARMACEUTICALS via MCDERMOTT WILL & SCHULTE LLP
2010 · second_quarter · RR
Health care, patent law
Health care, patent law
Health care, patent law
DIABETES ACCESS TO CARE COALITION via MCDERMOTT WILL & SCHULTE LLP
2010 · second_quarter · RR
Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program
AMERICAN SPECIALTY HEALTH, INC. via MCDERMOTT WILL & SCHULTE LLP
2010 · first_quarter · Q1
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation, such as H.R. 3590, Patient Protection and Affordable Care Act (passed); and H.R. 3962, House Affordable Health Care for America Act (did not get enacted). Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2010 · first_quarter · Q1
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2010 · first_quarter · Q1
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SPECIALTY HEALTH, INC. via MCDERMOTT WILL & SCHULTE LLP
2009 · fourth_quarter · Q4
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation. Ensuring medical loss ratio legislation takes into account the unique characteristics of specialty plans for chiropractic and other wellness services. Promoting prevention and wellness programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SANOFI-AVENTIS U.S. INC. via MCDERMOTT WILL & SCHULTE LLP
2009 · fourth_quarter · Q4
FDA approval of follow on biologics, including S. 1679
Filing targets: Food & Drug Administration (FDA), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2009 · fourth_quarter · Q4
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2009 · fourth_quarter · Q4
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLERGAN, INC. via MCDERMOTT WILL & SCHULTE LLP
2009 · fourth_quarter · Q4
Issues related to Section 340B of the Public Health Service Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SANOFI-AVENTIS U.S. INC. via MCDERMOTT WILL & SCHULTE LLP
2009 · fourth_quarter · RR
FDA approval of follow on biologics, including S. 1679
AMERICAN SPECIALTY HEALTH, INC. via MCDERMOTT WILL & SCHULTE LLP
2009 · third_quarter · Q3
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL GEOGRAPHIC FAIRNESS COALITION via MCDERMOTT WILL & SCHULTE LLP
2009 · third_quarter · Q3
Seeking to maintain current criteria for geographic reclassification for hospitals under Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2009 · third_quarter · Q3
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220. Seeking TRICARE coverage for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2009 · third_quarter · Q3
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SPECIALTY HEALTH, INC. via MCDERMOTT WILL & SCHULTE LLP
2009 · second_quarter · Q2
Promoting complimentary alternative medicine services, including but not limited to chiropractic, in health care reform legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH MANAGEMENT ASSOCIATES, INC. via MCDERMOTT WILL & SCHULTE LLP
2009 · second_quarter · Q2
Legislation affecting physician hospital ownership.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2009 · second_quarter · Q2
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220..
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699 and S. 1220.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2009 · second_quarter · Q2
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699 and S. 1220.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH MANAGEMENT ASSOCIATES, INC. via MCDERMOTT WILL & SCHULTE LLP
2009 · first_quarter · Q1
Legislation affecting physician hospital ownership.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2009 · first_quarter · Q1
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2009 · first_quarter · Q1
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests; seeking to advance H.R. 1699.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed test; seeking to advance H.R. 1699.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH MANAGEMENT ASSOCIATES, INC. via MCDERMOTT WILL & SCHULTE LLP
2009 · first_quarter · RR
legislation affecting physician hospital ownership
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2008 · fourth_quarter · Q4
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2008 · fourth_quarter · Q4
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HOSPITAL GEOGRAPHIC FAIRNESS COALITION via MCDERMOTT WILL & SCHULTE LLP
2008 · third_quarter · Q3
Seeking to maintain current criteria for geographic reclassification for hospitals under Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2008 · third_quarter · Q3
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION FOR 21ST CENTURY MEDICINE via MCDERMOTT WILL & SCHULTE LLP
2008 · third_quarter · Q3
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CYTOMEDIX, INC. via MCDERMOTT WILL & SCHULTE LLP
2008 · fourth_quarter · RR
Medicare coverage and reimbursement for wound healing therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE